• Establishing a Regenerative Medicine Center  at the Galeazzi Orthopedic Institute, Milan, Italy

    Establishing a Regenerative Medicine Center at the Galeazzi Orthopedic Institute, Milan, Italy

    Regen Med recently executed inCytes™ license and related agreements with the Galeazzi Orthopedic Institute (“IOG”), one of the largest orthopedic research/clinical centers in Europe.  IOG in turn is one of 18 hospitals owned by Gruppo San Donato (“GSD”) — 4 million patients annually, 5,100 beds, 4,000 physicians.

    Using inCytes™ as the backbone, IOG and GSD are consolidating under a separate brand — “REGAIN” —  the development, standardization and delivery of regenerative medicine procedures.  REGAIN is scheduled to commence operations this September in orthopedic, oral and plastic/reconstructive surgery, as well as physiatry and sports medicine.  Expansion of REGAIN activities to other disciplines will follow shortly thereafter.

    Regen Med will provide a number of services to support REGAIN, including clinical data collection and reports, education and training, coordination with vendors, studies/trials, payor reimbursement, product incubation and international patient referrals.

    For additional information, please refer to our Corporate Literature page, or contact us at info@rgnmed.com.

    Read more →
  • InCytes Software: Q2/17 Release

    InCytes Software: Q2/17 Release


    InCytes™ is an integrated software-as-a-service platform supporting the collection and utilization of data-sets underlying evidence-based medical therapies. Developed by an international network of scientific and clinical thought-leaders, the platform provides value to healthcare professionals, payors, researchers, industry, professional medical societies and regulators.

    InCytes’ longitudinal and verifiable data-sets can be used to analyze virtually any clinical path, protocol, indication or procedure – in an efficient, intuitive manner. It further supports the execution of studies/trials, cost/benefit analyses, decisions based on precision medicine, and other healthcare-delivery value assessments.

    In all, InCytes is much more than an electronic healthcare record or electronic data capture system. To learn more, please download our product brochure by clicking the link above.

    Read more →
  • Bringing Cell Therapies to the Clinic: Brochure Download

    Bringing Cell Therapies to the Clinic: Brochure Download

    Despite the broad potential of RMP’s, clinical translation has been uneven. Barriers to broader adoption include regulatory uncertainty, paucity of clinically relevant data, the dynamic nature of modern cell science, less than-ethical “stem cell” marketing, non-standardized protocols, uncertain revenue models, and inadequate education and training of healthcare professionals and patients alike. As with many major advances in medicine – hematology, IVF, orthopedic surgery to name but a few – broad adoption of RMP’s will require clinical/ scientific leadership, protocol standardization, professional and patient education, and regulatory and third party payor acceptance. Regen Med — comprising internationally recognized clinical and thought leaders in regenerative medicine — is dedicated to assisting hospitals as well as smaller medical practices address these issues. Being product agnostic, Regen Med is able to align its interests with its “Affiliates” in establishing approaches to regenerative medicine which are evidence based, regulatorily-compliant and economically sensible.

    To read more, please download our full brochure: HCTCenter_Brochure_DIGITAL

    Read more →
  • HCT Centers: Frequently Asked Questions Download

    Human Cell/Tissue Centers (“HCT”) support the delivery of regenerative medicine procedures in a manner designed to obtain consistent clinical results. Whether as a large teaching hospital, or small, specific practice, an HCT center is a reliable, profitable and regulatorily compliant assets for the establishment of a regenerative medicine practice. To learn more about HCT Centers and gain answers to frequently asked questions by our affiliates, please click here.

    Read more →
  • Regen Med for Healthcare Professionals

    Regen Med supports hospitals, clinics and physicians around the world in the delivery of regulatorily-compliant and evidence-based regenerative medicine procedures (“RMP’s”). Together, the Company’s management, Clinical/Scientific Advisory Board, and affiliated thought-leaders provide many decades of international surgical, medical, scientific, financial, legal and business experience directly relevant to the application of regenerative medicine in a clinical setting. To learn more about how Regen Med works with Healthcare Professionals, download the full PDF here.

    Read more →